Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Secured Thyroidectomy With Intraoperative Methylene Blue Using (bluethyroid)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2010 by SB Istanbul Education and Research Hospital.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Bezmialem Vakif University
Information provided by:
SB Istanbul Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT01347606
First received: May 3, 2011
Last updated: NA
Last verified: January 2010
History: No changes posted

May 3, 2011
May 3, 2011
January 2010
January 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Secured Thyroidectomy With Intraoperative Methylene Blue Using
Prospective Randomized Technical Study
Thyroid surgery has potential risks. Intraoperative organ (such as parathyroides) extraction and vascular or neural (such as recurrent nervus) injuries are most important ones. This research is aim to prevention of these via intraoperative methylene blue using.
Thyroid surgery has potential risks. Intraoperative organ (such as parathyroides) extraction and vascular or neural (such as recurrent nervus) injuries are most important ones. This research is aim to prevention of these via intraoperative methylene blue using. In the operation when thyroid lobes manipulated to medially, methylene blue will be sprayed to this area. Dying patternes of tissues (thyroid tissue, oparathyroid tissues, arteries, venules and neural structures) will ensure to identification the tissues.
Observational
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
thyroid tissue
Probability Sample
thyroidectomy indicated patients
Thyroid
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
20
July 2011
January 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Thyroidectomy indicated patients

Exclusion Criteria:

  • Recurrent disease
  • Additional disease
Both
18 Years to 70 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Turkey
 
NCT01347606
4-Aysan
No
Not Provided
Not Provided
erhan aysan, Bezmialem Vakif University
SB Istanbul Education and Research Hospital
Bezmialem Vakif University
Principal Investigator: erhan aysan, Assoc. Prof. Bezmialem Vakif University
SB Istanbul Education and Research Hospital
January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP